GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals

AIDS

Volumn 20, Issue 3, 2006, Pages 379-386

  Li, Chengyao ^a   Collini, Paul ^b   Danso, Kwabena ^b   Owusu Ofori, Shirley ^b   Dompreh, Albert ^b   Candotti, Daniel ^a   Opare Sem, Ohene ^b   Allain, Jean Pierre ^c,d  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Cambridge Blood Centre   (United Kingdom)

Author keywords

Co infection; GB virus C; HIV 1; Viral load

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; POPULATION RESEARCH; PREGNANT WOMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SUPERINFECTION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; VIRUS VIRULENCE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; GHANA; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 33645028684     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1872-2040(06)60020-0     Document Type: Article

References (36)

1. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271:505-508.
2. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48:60-67.
3. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336:747-754.
4. Laskus T, Wang LF, Radkowski M, Jang SJ, Vargas H, Dodson F, et al. Hepatitis G virus infection in American patients with cryptogenic cirrhosis: no evidence for liver replication. J Infect Dis 1997; 176:1491-1495.
5. Tucker TJ, Smuts HE, Eedes C, Knobel GD, Eickhaus P, Robson SC, et al. Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. J Med Virol 2000; 61:52-58.
6. Xiang J, Wunschmann S, Schmidt W, Shao J, Stapleton JT. Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 2000; 74:9125-9133.
7. Stapleton JT. GB virus type C/Hepatitis G virus. Semin Liver Dis 2003; 23:137-148.
8. Heringlake S, Ockenga J, Tillmann HL, Trautwein C, Meissner D, Stoll M, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998; 177:1723-1726.
9. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179:783-789.
10. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345:715-724.
11. Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345:707-714.
12. Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350:981-990.
13. Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, Morsica G, Pizzaferri P, et al. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. Antivir Ther 2005; 10:109-117.
14. Nattermann J, Nischalke HD, Kupfer B, Rockstroh J, Hess L, Sauerbruch T, Spengler U. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003; 17:1457-1462.
15. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1 alpha, MIP-1beta, and SDF-1. Lancet 2004; 363:2040-2046.
16. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002; 16:2482-2485.
17. Brumme ZL, Chan KJ, Dong WW, Mo T, Wynhoven B, Hogg RS, et al. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. AIDS 2002; 16:1929-1933.
18. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18:877-886.
19. Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, et al. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 2005; 191:678-685.
20. Kaye S, Howard M, Alabi A, Hansmann A, Whittle H, Schim van der Loeff M. No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2. Clin Infect Dis 2005; 40:876-878.
21. Allain JP, Candotti D, Soldan K, Sarkodie F, Phelps B, Giachetti C, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003; 101:2419-2425.
22. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Pre-donation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005; 45:133-140.
23. Fischetti L, Opare-Sem O, Candotti D, Lee H, Allain JP. Higher viral load may explain the dominance of CRF02_AG in the molecular epidemiology of HIV in Ghana. AIDS 2004; 18:1208-1210.
24. Li C, Allain JP, Candotti D. Absence of detectable West Nile virus and Dengue virus viremia in blood donors, pregnant women and young children from Ghana, West Africa [letter]. Submitted.
25. Petrik J, Guella L, Wight DG, Pearson GM, Hinton J, Parker H, et al. Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus. Gut 1998; 42:103-106.
26. Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, et al. Reply to George and to Stapleton et al. [letter]. J Infect Dis 2005; 191:2158-2160.
27. Sathar MA, York DF, Gouws E, Coutsoudis A, Coovadia HM. GB virus type C coinfection in HIV-infected African mothers and their infants, KwaZulu Natal, South Africa. Clin Infect Dis 2004; 38:405-409.
28. Sathar MA, Soni PN, Naicker S, Conradie J, Lockhat F, Gouws E. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa. J Med Virol 1999; 59:38-44.
29. Tuveri R, Perret JL, Delaporte E, Nguemby-Mbina C, D'Allones LR, Henzel D, et al. Prevalence and genetic variants of hepatitis GB-C/HG and TT viruses in Gabon, equatorial Africa. Am J Trop Med Hyg 2000; 63:192-198.
30. Weintrob AC, Hamilton JD, Hahn C, Klinzman D, Moyo G, Zdunek D, et al. Active or prior GB virus C infection does not protect against vertical transmission of HIV in coinfected women from Tanzania. Clin Infect Dis 2004; 38:e46-e48.
31. Luppi P. How immune mechanisms are affected by pregnancy. Vaccine 2003; 21:3352-3357.
32. Biedermann K, Flepp M, Fierz W, Joller-Jemelka H, Kleihues P. Pregnancy, immunosuppression and reactivation of latent toxoplasmosis. J Perinat Med 1995; 23:191-203.
33. Milchev N, Pekhlivanov B, Krusteva M, Chalukova Zh, Stankova G. The immune changes at the beginning of pregnancy [abstract]. Akush Ginekol (Sofiia) 1990; 29:13-16.
34. Baboonian C, Grundy JE, Lever AM, Griffiths PD. Effect of pregnancy plasma upon in vitro parameters of cell mediated immunity. FEMS Microbiol Immunol 1989; 1:189-197.
35. Glassman AB, Bennett CE, Christopher JB, Self S. Immunity during pregnancy: lymphocyte subpopulations and mitogen responsiveness. Ann Clin Lab Sci 1985; 15:357-362.
36. Adu-Sarkodie Y, Sangare A, d'Almeida OA, Kanmogne GD. Distribution of CD4+ T-lymphocytes levels in patients with clinical symptoms of AIDS in three west African countries. J Clin Virol 1998; 11:173-181.